A detailed history of Quartz Partners, LLC transactions in Supernus Pharmaceuticals, Inc. stock. As of the latest transaction made, Quartz Partners, LLC holds 27,679 shares of SUPN stock, worth $999,765. This represents 0.54% of its overall portfolio holdings.

Number of Shares
27,679
Holding current value
$999,765
% of portfolio
0.54%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

BUY
$25.77 - $35.16 $713,287 - $973,193
27,679 New
27,679 $863 Million

Others Institutions Holding SUPN

About SUPERNUS PHARMACEUTICALS, INC.


  • Ticker SUPN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 53,495,300
  • Market Cap $1.93B
  • Description
  • Supernus Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of products for the treatment of central nervous system (CNS) diseases in the United States. Its commercial products are Trokendi XR, an extended release topiramate product indicated for the treatment of epilepsy, as well as for the prop...
More about SUPN
Track This Portfolio

Track Quartz Partners, LLC Portfolio

Follow Quartz Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Quartz Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Quartz Partners, LLC with notifications on news.